معرفی
Dr. Anand Kumar is a Professor in the Department of Internal Medicine at the Max Rady College of Medicine, University of Manitoba, with cross-appointments in Pharmacology and Therapeutics. He is an attending physician at Health Sciences Centre and St-Boniface Hospital. His research focuses on septic shock, ICU management of pandemics (e.g., COVID-19), and optimizing antimicrobial therapy. He leads the Cooperative Antimicrobial Therapy of Septic Shock Research Group and is a member of the CHIRON Research Group.
Education & Training:
- Fellowship in Infectious Diseases, University of Wisconsin, Madison (1996)
- Research Fellowship in Cardiovascular function in sepsis (1994)
- Fellowship in Critical Care Medicine, Rush University (1991)
- Fellowship in Critical Care Medicine, University of Manitoba (1990)
- Residency in Internal Medicine, The Toronto Hospital (1989)
- Doctor of Medicine, University of Toronto (1986)
Research Interests:
Dr. Kumar’s work combines translational research and clinical practice. He uses small animal models and a clinical septic shock database (9,000+ patients) to study mechanisms of sepsis and improve treatments. His seminal paper on antimicrobial therapy has been cited over 5,000 times. Key areas include pandemic ICU management, circulatory shock, and inflammatory myocardial dysfunction.
Awards & Honors:
- 1993-2005: Multiple Young Investigator and Best Abstract Awards from critical care societies.
- Recognized as a top researcher in sepsis and antibiotic therapy.
Labs & Teams:
He heads the Cooperative Antimicrobial Therapy of Septic Shock Group and collaborates with the CHIRON Research Group to advance sepsis research. His work emphasizes interdisciplinary approaches to pandemic preparedness and critical care innovation.
